A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
about
Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling TechniquesAssessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data.Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.Health care budgets and vaccine programs: a time for review and prioritizationEffect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.Comprehensive control (or elimination) of hepatitis B virus transmission in the United StatesCost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.An economic assessment of pre-vaccination screening for hepatitis A and B.GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.The current economic burden of cirrhosis.Moving towards a universal hepatitis B vaccine program for Canadian childrenThe transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes.Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illness.Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.Update on childhood immunizations.Adolescent hepatitis B immunisation--should it be the law?Is vaccination against hepatitis B efficient? A review of world literature.Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies.RECOMMENDATION FOR HEPATITIS - B VACCINATION.Cost-effectiveness analysis of alternative factor VIII products in treatment of haemophilia A.Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece.The cost effectiveness of hepatitis immunization for US college students.A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.Awareness and utilization of the hepatitis B vaccine among young men in the Ann Arbor area who have sex with men.The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets.Population-based versus practice-based recall for childhood immunizations: a randomized controlled comparative effectiveness trial.
P2860
Q26774500-5F17D419-0828-42B4-B34C-F02EE929C59CQ30861975-D08028D6-6BEF-4D32-BE29-C2A9A5C8373CQ34147433-61443B9C-741A-410C-B99E-FBF2930D1A65Q34276706-763814C6-9C56-411B-9F4C-1EDF927FDAA6Q34343621-229FC520-A946-4BE8-A7E3-BA136B23F894Q34441991-7C8935E3-E760-4231-A7F6-A9A519F4F834Q34712297-384C085D-4515-482D-A5AA-452009F719CDQ34756504-52E2779E-0182-47BF-A77F-8159A7200EFBQ35441596-07C8F3E9-AC68-45C4-9733-44CB3AC5EF76Q35691411-905C84BD-8148-45D2-85BC-2160AA147120Q35892947-3405D0E8-1350-478B-AF48-840692448B02Q36503486-31D7174B-6504-47CD-BB3B-42B382084785Q36799786-04763358-2714-44AF-8F6C-CEA418AE20E9Q37264961-F5E85F80-9FF1-47DA-8D83-7EB357185EF2Q37409653-D0FBFB7B-9559-4856-8503-1C9D854DCAECQ37955240-62793C13-B4AA-417E-8F55-5C26D4A7FD0AQ38569680-EDAEE334-EA04-49C0-9447-CA437CF1D226Q40692736-E09E05DE-34AB-4F33-8A22-6B764BC91FAEQ40745292-1973527E-0E5F-4352-9379-C18694D5982DQ40880154-EA79EDCB-4F65-489A-808D-F537734AE560Q41142359-268A46FA-6919-45DD-86FE-92DFC0CE5D36Q41684827-E51CEF71-88FF-40EE-8CD6-920BCE25FD69Q43330621-00E21EFD-C602-433D-81BD-005B0817C618Q44864303-4365C703-31E6-46CA-B31F-4C4125AB1778Q44930328-5395E1D8-FD95-415D-AEE0-A914CD411290Q45737159-31A1B5EB-152F-46D0-84D4-06304CA98CFBQ50538208-82ACC861-3FCA-4496-B6F3-5A45183DE50DQ53539667-2D6E4126-FFD1-4B2C-9F42-24D253231580Q55686325-DA6DE2BA-7081-4C4F-BF80-DCE91DEE5C88
P2860
A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@en
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@nl
type
label
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@en
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@nl
prefLabel
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@en
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@nl
P2093
P1476
A reappraisal of hepatitis B v ...... g cost-effectiveness analysis.
@en
P2093
Fendrick AM
Hillman AL
Schwartz JS
P304
P356
10.7326/0003-4819-118-4-199302150-00009
P407
P577
1993-02-01T00:00:00Z